Candela Solé-Lleonart

Candela Solé-Lleonart

Auto-generated profile, based on publicly available information

Candela Solé-Lleonart

Hospital Universitari de Vic, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 May 2017 in Anesthesiology
Verified
Journal Article
Closed access
CSCandela Solé-Lleonart
Candela Solé-Lleonart
Jean-Jacques RoubyJean-Jacques Rouby
Jean-Jacques Rouby
SBStijn Blot
Stijn Blot
GPGaryfallia Poulakou
Garyfallia Poulakou
JCJean Chastre
Jean Chastre
JRJordi Rello
Jordi Rello
Background: Nebulization of antiinfective agents is a common but unstandardized practice in critically ill patients. Methods: A systematic review of 1,435 studies was performed in adults receiving invasive mechanical ventilation. Two different administration strategies (adjunctive and substitute) were considered clinically relevant. Inclusion was restricted to studies using jet, ultrasonic, and vibrating-mesh nebulizers. Studies involving children, colonized-but-not-infected adults, and cystic fibrosis patients were excluded. Results: Five of the 11 studies included had a small sample size (fewer than 50 patients), and only 6 were randomized. Diversity of case-mix, dosage, and devices are sources of bias. Only a few patients had severe hypoxemia. Aminoglycosides and colistin were the most common antibiotics, being safe regarding nephrotoxicity and neurotoxicity, but increased respiratory complications in 9% (95% CI, 0.01 to 0.18; I2 = 52%), particularly when administered to hypoxemic patients. For tracheobronchitis, a significant decrease in emergence of resistance was evidenced (risk ratio, 0.18; 95% CI, 0.05 to 0.64; I2 = 0%). Similar findings were observed in pneumonia by susceptible pathogens, without improvement in mortality or ventilation duration. In pneumonia caused by resistant pathogens, higher clinical resolution (odds ratio, 1.96; 95% CI, 1.30 to 2.96; I2 = 0%) was evidenced. These findings were not consistently evidenced in the assessment of efficacy against pneumonia caused by susceptible pathogens. Conclusions: Performance of randomized trials evaluating the impact of nebulized antibiotics with more homogeneous populations, standardized drug delivery, predetermined clinical efficacy, and safety outcomes is urgently required. Infections by resistant pathogens might potentially have higher benefit from nebulized antiinfective agents. Nebulization, without concomitant systemic administration of the drug, may reduce nephrotoxicity but may also be associated with higher risk of respiratory complications.

1 September 2017 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
JRJordi Rello
Jordi Rello
Jean-Jacques RoubyJean-Jacques Rouby
Jean-Jacques Rouby
CSC. Sole-Lleonart
C. Sole-Lleonart
JCJ. Chastre
J. Chastre
SBS. Blot
S. Blot
JRJason Roberts
Jason Roberts

1 April 2016 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
CSC. Solé-Lleonart
C. Solé-Lleonart
JRJason Roberts
Jason Roberts
JCJ. Chastre
J. Chastre
GPG. Poulakou
G. Poulakou
LPL.B. Palmer
L.B. Palmer
JRJordi Rello
Jordi Rello


8 March 2016 in Respiratory Care
Verified
Journal Article
Closed access
PDF file
CSCandela Solé-Lleonart
Candela Solé-Lleonart
Jean-Jacques RoubyJean-Jacques Rouby
Jean-Jacques Rouby
JCJean Chastre
Jean Chastre
GPGaryfallia Poulakou
Garyfallia Poulakou
LPLucy B Palmer
Lucy B Palmer
JRJordi Rello
Jordi Rello
BACKGROUND: Intratracheal antibiotic administration is increasingly used for treating respiratory infections. Limited information is available on delivery devices, techniques, and safety. METHODS: An online survey on intratracheal administration of anti-infective agents in mechanically ventilated adults was answered by health-care workers from 192 ICUs to assess the most commonly used devices, current delivery practices, and safety issues. We investigated whether ICU usage experience (≥3 y) impacted its performance. RESULTS: Intratracheal antibiotic administration was a current practice in 87 ICUs (45.3%), with 40 (46%) having experience with the technique (≥3 y). Sixty-six (78.6%) of 84 health-care workers reported avoiding intratracheal antibiotic administration due to an absence of evidence-based guidelines (78.6%). Jet nebulizers were the most commonly used devices for delivery, in 24 less experienced ICUs (27.6%) and in 18 (20.7%) experienced ICUs. Direct tracheal instillation (6; 6.9%) was still considered for drug prescription in 12 ICUs (6.9%). More experience resulted in neither greater adherence to measures improving the drug's delivery efficiency (93 measures in the experienced group; 27.9%) nor a greater adoption of measures to increase safety. Indeed, the expiratory filter was changed after each nebulization in only 2 experienced ICUs (6.9%), whereas 15 (51.7%) changed it daily instead. CONCLUSIONS: Intratracheal antibiotic administration is a common therapeutic modality in ICUs, but inadequate practices were widely encountered, independent of the level of experience with the technique. This suggests a need to develop standardization to reduce variability and improve safety and efficacy.